Sector consensus Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 04:00:00 14/08/2026 HKT			5-day change	1st Jan Change
15.84 ^USD	-0.69%		+0.83%	+1.02%

08-06	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
MONTE ROSA THERAPEUTICS, INC.	28.5	+79.92%	6
LONZA GROUP AG	681.13	+18.91%	23
REVOLUTION MEDICINES, INC.	221.9	+9.85%	21
BEONE MEDICINES AG	433.02	+21.63%	27
IQVIA HOLDINGS INC.	275.17	+13.93%	18
CELLTRION, INC.	264,708.89	+31.04%	24
ASCENDIS PHARMA A/S	267.19	+25.19%	18
MEDPACE HOLDINGS, INC.	581.83	-0.02%	12
EUROFINS SCIENTIFIC SE	72.53	+3.46%	14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	281	-0.1%	14
ICON PUBLIC LIMITED COMPANY	185.56	+10.8%	16
PHARMARON BEIJING CO., LTD.	38.15	-23.4%	11
BIO-TECHNE CORPORATION	70.73	-2%	11
ABIVAX	138.56	+29.98%	6
PRAXIS PRECISION MEDICINES, INC.	623.68	+69.27%	19
APOGEE THERAPEUTICS, INC.	134.85	+0.3%	11
TEMPUS AI, INC.	62.64	+15.39%	14
PROTAGONIST THERAPEUTICS, INC.	165.31	+9.17%	13
KYMERA THERAPEUTICS, INC.	130.91	+14.41%	22
IONIS PHARMACEUTICALS, INC.	89.33	+59.9%	21
Average	13,459.54	+19.38%	16
Weighted average by Cap.	23,498.75	+16.54%	19